Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3 H -1,2,4-triazole-3-thione
Journal of Medicinal Chemistry · 22.08.2024 · 67 (16) · 14184-14199
DOI: 10.1021/acs.jmedchem.4c01008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 05.08.2024. Verfasst von David S Yoon und 18 weiteren Autor:innen. Beteiligte Einrichtung: Research and Early Development, Bristol Myers Squibb, P.O. Box 5400, Princeton, New Jersey 08543-5400, United States. Hauptthemen laut MEDLINE: Triazoles, Galactose, Galectin 3. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Galectin-3 (Gal-3) is a carbohydrate binding protein that has been implicated in the development and progression of fibrotic diseases. Proof-of-principal animal models have demonstrated that inhibition of Gal-3 is a potentially viable pathway for the treatment of fibrosis─with small molecule Gal-3 inhibitors advanced into clinical trials. We hereby report the discovery of novel galactose-based monosaccharide Gal-3 inhibitors comprising 2-methyl-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione (compound 20) and 4-phenyl-4H-1,2,4-triazole (compound 15). Notably, hindered rotation caused by steric interaction between the 3-thione and ortho-trifluoromethyl group of compounds 20, 21 induced formation of thermodynamically stable atropisomers. Distinct X-ray cocrystal structures of 20 and 21 were obtained, which clearly demonstrated that the configuration of 21 proscribes a key halogen bonding σ-hole interaction of 3-chloro with carbonyl oxygen of Gly182, thereby leading to significant loss in potency. Ultimately, 20 and 15 were evaluated in mouse pharmacokinetic studies, and both compounds exhibited oral exposures suitable for further in vivo assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research and Early Development, Bristol Myers Squibb, P.O. Box 5400, Princeton, New Jersey 08543-5400, United States.
- Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
ORCID-Profile: David S Yoon, Chunjian Liu, Li Xu, Bruce A Ellsworth, Alicia Regueiro-Ren
Zitieren
APA
Yoon, D. S., Liu, C., Jalagam, P. R., Feng, J., Wang, W., Swidorski, J. J., Xu, L., Hartz, R. A., Nair, S. K., Beno, B. R., Panda, M., Ghosh, K., Kumar, A., Sale, H., Shah, D., Mathur, A., Ellsworth, B. A., Cheng, D., & Regueiro-Ren, A. (2024). Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3 H -1,2,4-triazole-3-thione. Journal of Medicinal Chemistry, 67(16), 14184-14199. https://doi.org/10.1021/acs.jmedchem.4c01008
Vancouver
Yoon DS, Liu C, Jalagam PR, Feng J, Wang W, Swidorski JJ, et al. Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3 H -1,2,4-triazole-3-thione. Journal of Medicinal Chemistry. 2024;67(16):14184-14199. doi:10.1021/acs.jmedchem.4c01008
BibTeX
@article{Yoon2024,
author = {Yoon, David S and Liu, Chunjian and Jalagam, Prasada Rao and Feng, Jianxin and Wang, Wei and Swidorski, Jacob J and Xu, Li and Hartz, Richard A and Nair, Satheesh K and Beno, Brett R and Panda, Manoranjan and Ghosh, Kaushik and Kumar, Amit and Sale, Harinath and Shah, Devang and Mathur, Arvind and Ellsworth, Bruce A and Cheng, Dong and Regueiro-Ren, Alicia},
title = {Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3 H -1,2,4-triazole-3-thione},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {16},
pages = {14184--14199},
doi = {10.1021/acs.jmedchem.4c01008}
}
EUVIMED